Close Asset Management LTD Johnson & Johnson Transaction History

Close Asset Management LTD

$2.94 Billion
Q2 2024

A detailed history of Close Asset Management LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Close Asset Management LTD holds 97,498 shares of JNJ stock, worth $16.2 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

97,498

Previous 93,676 4.08%

Holding current value

$16.2 Million

Previous $14.8 Million 3.86%

% of portfolio

0.48%

Previous 0.54%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$144.38 - $157.78 $551,820 - $603,035	3,822 Added 4.08%	97,498 $14.2 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $466,436 - $489,033	3,005 Added 3.31%	93,676 $14.8 Million
Q4 2023 Feb 08, 2024	BUY	$145.6 - $158.88 $651,414 - $710,829	4,474 Added 5.19%	90,671 $14.2 Million
Q3 2023 Oct 11, 2023	BUY	$155.75 - $174.48 $680,939 - $762,826	4,372 Added 5.34%	86,197 $13.4 Million
Q2 2023 Jul 26, 2023	BUY	$154.35 - $166.11 $690,253 - $742,843	4,472 Added 5.78%	81,825 $13.5 Million
Q1 2023 Apr 19, 2023	BUY	$151.05 - $180.26 $724,133 - $864,166	4,794 Added 6.61%	77,353 $12 Million
Q4 2022 Jan 27, 2023	BUY	$160.2 - $179.79 $554,131 - $621,893	3,459 Added 5.01%	72,559 $12.8 Million
Q3 2022 Oct 26, 2022	BUY	$161.33 - $179.52 $333,146 - $370,708	2,065 Added 3.08%	69,100 $11.3 Million
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $401,637 - $444,191	2,388 Added 3.69%	67,035 $11.9 Million
Q4 2021 Jan 27, 2022	SELL	$155.93 - $173.01 $485,098 - $538,234	-3,111 Reduced 4.59%	64,647 $11.1 Million
Q3 2021 Nov 04, 2021	BUY	$161.5 - $179.47 $174,581 - $194,007	1,081 Added 1.62%	67,758 $10.9 Million
Q2 2021 Jul 27, 2021	SELL	$159.48 - $171.07 $336,502 - $360,957	-2,110 Reduced 3.07%	66,677 $11 Million
Q1 2021 May 07, 2021	SELL	$153.07 - $170.48 $172,969 - $192,642	-1,130 Reduced 1.62%	68,787 $11.3 Million
Q4 2020 Jan 22, 2021	BUY	$137.11 - $157.38 $279,567 - $320,897	2,039 Added 3.0%	69,917 $11 Million
Q3 2020 Oct 30, 2020	BUY	$140.38 - $153.83 $24,426 - $26,766	174 Added 0.26%	67,878 $10.1 Million
Q2 2020 Jul 28, 2020	SELL	$128.81 - $155.51 $1.56 Million - $1.89 Million	-12,133 Reduced 15.2%	67,704 $9.51 Million
Q1 2020 May 05, 2020	SELL	$111.14 - $153.99 $3,667 - $5,081	-33 Reduced 0.04%	79,837 $10.5 Million
Q4 2019 Jan 22, 2020	SELL	$127.5 - $146.44 $83,257 - $95,625	-653 Reduced 0.81%	79,870 $11.6 Million
Q3 2019 Nov 06, 2019	SELL	$126.95 - $142.14 $83.8 Million - $93.9 Million	-660,496 Reduced 89.13%	80,523 $10.4 Million
Q2 2019 Aug 01, 2019	BUY	$131.15 - $144.24 $13.7 Million - $15.1 Million	104,411 Added 16.4%	741,019 $103 Million
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $79.2 Million - $88.1 Million	630,193 Added 9823.74%	636,608 $89 Million
Q4 2018 Jan 28, 2019	SELL	$122.84 - $147.84 $75.1 Million - $90.4 Million	-611,143 Reduced 98.96%	6,415 $540,000
Q3 2018 Nov 09, 2018	BUY	$121.58 - $142.88 $30.2 Million - $35.5 Million	248,658 Added 67.41%	617,558 $83.7 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $2.83 Million - $3.35 Million	22,639 Added 6.54%	368,900 $45.9 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $8.63 Million - $9.45 Million	65,774 Added 23.45%	346,261 $48.4 Million
Q3 2017 Feb 13, 2018	BUY	$129.47 - $135.38 $12 Million - $12.5 Million	92,450 Added 49.17%	280,487 $0
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $17.3 Million - $18.1 Million	133,461 Added 244.54%	188,037 $24.4 Million
Q2 2017 Feb 13, 2018	BUY	N/A	34,009 Added 165.36%	54,576 $7.22 Million
Q2 2017 Nov 14, 2017	SELL	N/A	-34,313 Reduced 62.52%	20,567 $0
Q1 2017 Feb 13, 2018	BUY	N/A	34,217 Added 165.6%	54,880 $6.83 Million
Q1 2017 Nov 14, 2017	SELL	N/A	-638 Reduced 3.0%	20,663 $2.57 Million
Q4 2016 Nov 14, 2017	BUY	N/A	21,301	21,301 $2.46 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.

Account

Close Asset Management LTD Johnson & Johnson Transaction History